Abstract
Salt sensitivity is regarded as an important contributor to the higher risk of hypertension in black people as compared with whites. This finding is in agreement with a better response to diuretics than to monotherapy with angiotensin-converting enzyme (ACE) inhibitor in black subjects. It is important to remember that the hypotensive effect of ACE inhibitor is augmented in patients on a thiazide diuretic. Moreover, the antihypertensive response to a specific drug varies among black patients. Thus, ACE inhibitors should also be viewed as important options to treat hypertensive black subjects. Results from clinical trials support an emphasis on lifestyle modification and a more intensive blood pressure lowering by pharmacological interventions to reduce the large black–white gap in cardiovascular events and end-stage renal disease (ESRD) attributed to hypertension.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Savage DD, Watkins LO, Grim CE, Kumanyika SK . Hypertension in black populations. In: Laragh JH, Brenner BM (eds) Hypertension: Pathophysiology, Diagnosis and Management Raven Press: New York, NY 1990 1837–1852
Lopes AA, Hornbuckle K, James SA, Port FK . The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension Am J Kidney Dis 1994 24: 554–560
Lopes AA, Port FK . The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease Am J Kidney Dis 1995 25: 350–356
Grim CE, Henry JP, Myers H . High blood pressure in blacks: salt, slavery, survival, stress, racism. In: Laragh JH, Brenner BM (eds) Hypertension: Pathophysiology, Diagnosis and Management Raven Press: New York, NY 1995 171–207
Eisner GM . Hypertension: racial differences Am J Kidney Dis 1990 16: 35–40
Campese VM . Salt sensitivity in hypertension. Renal and cardiovascular implications Hypertension 1994 23: 531–550
Morimoto A et al. Sodium sensitivity and cardiovascular events inpatients with essential hypertension Lancet 1997 350: 1734–1737
Laviades C, Varo N, Diez J . Transforming growth factor beta in hypertensives with cardiorenal damage Hypertension 2000 36: 517–522
Suthanthiran M et al. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage Proc Natl Acad Sci USA 2000 97: 3479–3484
Frohlich ED . Hemodynamic differences between blackpatients and whitepatients with essential hypertension. State of the art lecture Hypertension 1990 15: 675–680
Parmer RJ, Stone RA, Cervenka JH . Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium Hypertension 1994 24: 752–757
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report Arch Intern Med 1997 157: 2413–2446
Svetkey LP et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial Arch Intern Med 1999 159: 285–293
Brancati FL, Appel LJ, Seidler AJ, Whelton PK . Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet. A randomized, double-blind, placebo-controlled trial Arch Intern Med 1996 156: 61–67
Wassertheil-Smoller S et al. The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life Am J Hypertens 1992 5: 37–44
Bond V et al. Aerobic exercise attenuates blood pressure reactivity to cold pressor test in normotensive, young adult African- American women Ethn Dis 1999 9: 104–110
Materson BJ et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents N Engl J Med 1993 328: 914–921
Li J, Zhou C, Yu L, Wang H . Renal protective effects of blocking the intrarenal renin-angiotensin system Hypertens Res 1999 22: 223–228
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide Br J Clin Pharmacol 1982 14: 97S–101S
Norton GR et al. Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects Am J Hypertens 1999 12: 563–571
Agodoa L . African American Study of Kidney Disease and hypertension (AASK): clinical trial update Ethn Dis 1998 8: 249–253
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lopes, A. Hypertension in black people: pathophysiology and therapeutic aspects. J Hum Hypertens 16 (Suppl 1), S11–S12 (2002). https://doi.org/10.1038/sj.jhh.1001333
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001333
Keywords
This article is cited by
-
Profile and predictor of health-related quality of life among hypertensive patients in south-western Nigeria
BMC Cardiovascular Disorders (2009)